Summary

The cell expansion market is projected to reach USD 26.7 billion by 2029 from an estimated USD 14.3 billion in 2024, at a CAGR of 13.3% during the forecast period of 2024 to 2029. The growth of this market can be attributed to increasing prevalence of chronic diseases. The rising rate of chronic diseases such as cancer is propelling the need of cell based therapies such as cell & gene therapy, tissue engineering, and regenerative medicine. The rising deamd for innovative cell based therapies and novel therapeutics is propelling the need of cell expansion. This trend is expected to drive the growth of the cell expansion market in the coming years.
“The biopharmaceutical production segment accounted for the largest share of by application segment in 2023.”
In 2023, the biopharmaceutical production segment accounted for the largest share of by application segment in the global cell expansion market. Biopharmaceutical production include monoclonal antibody production, vaccine production, and other therapeutic protein production. The growing investments and fundings for the development of novel drug products and rising demand for biological therapies such as monoclonal antibosies, vaccines, and therapeutic proteins are promoting the growth of biopharmaceutical production in cell expansion market.
“The US has continued to dominate the cell expansion market during the forecast period of 2024-2029.”
The US dominated the cell expansion market in North America in 2023. The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Additionally, the US is home to some of the world’s leading academic research institutes, including Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT). These institutes conduct cutting-edge research in life sciences, including drug discovery and biotechnology, which involve adoption of cell expansion techniques, resulting to propel the market growth. Additionally, increasing fundings in the field of tissue engineering and regenerative medicine are also driving the growth of cell expansion market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: Managers - 55%, CXO & Directors - 20%, and Executives - 25%
• By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Danaher Corporation (US)
• Merck KGaA (Germany)
• Sartorius AG (Germany)
• Corning Incorporated (US)
• Lonza (Switzerland)
• Terumo Corporation (Japan)
• Eppendorf SE (Germany)
• FUJIFILM Corporation (Japan)
• Bio-Techne (US)
• Repligen Corporation (US)
• Getinge AB (Sweden)
• Miltenyi Biotec (Germany)
• PerkinElmer Inc. (US)
• STEMCELL Technologies (Canada)
• PromoCell GmBHGmbH (Germany)
• HiMedia Laboratories (India)
• BD (US)
• Takara Bio Inc. (Japan)
• Shanghai Duoning Biotechnology Co., Ltd. (Japan)
• REPROCELL Inc. (Japan)
• PBS Biotech, Inc. (US)
• ACROBiosystems (US)
• Solida Biotech GmBH (Germany)
• Beijing CytoNiche Biotechnology Co., Ltd. (China)
• Neuromics (US)
• Bionet (Spain)
• Cellexus (UK)

Research Coverage:
This research report categorizes the cell expansion market by product (consumables and equipment), by cell type (human cells, animal cells, and other cell types), by application (biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, and other applications), by end user (pharmaceutical & biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell expansion market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. Also, it include new product launches, collaborations and acquisitions, and recent developments associated with the cell expansion market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell expansion market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (increasing prevalence of chronic diseases, rising investments and fundings in cell based research, and growing strategic alliances for the development of biotechnology industry), restraints (high cost of cell based therapies and ethical concern regarding cell biology), opportunities (growing opportunities in emerging economies, advances in 3D cell expansion technology), and Challenges (concern regarding supply chain and logistics) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the cell expansion market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell expansion market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany), Corning Incorporated (US), Lonza (Switzerland), Terumo Corporation (Japan), Eppendorf SE (Germany), FUJIFILM Corporation (Japan), Bio-Techne (US), Repligen Corporation (US), Getinge AB (Sweden), Miltenyi Biotec (Germany), PerkinElmer Inc. (US), STEMCELL Technologies (Canada), PromoCell GmBH (Germany), HiMedia Laboratories (India), BD (US), Takara Bio Inc. (Japan), Shanghai Duoning Biotechnology Co., Ltd. (Japan), REPROCELL Inc. (Japan), PBS Biotech, Inc. (US), ACROBiosystems (US), Solida Biotech GmBH (Germany), Beijing CytoNiche Biotechnology Co., Ltd. (China), Neuromics (US), Bionet (Spain), and Cellexus (UK), among others in the market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 84
1.1 STUDY OBJECTIVES 84
1.2 MARKET DEFINITION 84
1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY 85
1.3 STUDY SCOPE 85
1.3.1 MARKET SEGMENTATION 86
1.3.2 REGIONS COVERED 87
1.4 YEARS CONSIDERED 87
1.5 CURRENCY 88
1.6 STAKEHOLDERS 88
1.7 LIMITATIONS 88
1.8 SUMMARY OF CHANGES 89
1.9 RECESSION IMPACT 90
2 RESEARCH METHODOLOGY 91
2.1 RESEARCH DATA 91
FIGURE 1 RESEARCH DESIGN 91
2.1.1 SECONDARY DATA 92
2.1.2 PRIMARY DATA 93
FIGURE 2 BREAKDOWN OF PRIMARIES: CELL EXPANSION MARKET 93
2.2 MARKET ESTIMATION METHODOLOGY 94
FIGURE 3 CELL EXPANSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 94
2.3 BOTTOM-UP APPROACH 94
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 95
FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC. (2023) 95
2.4 INSIGHTS FROM PRIMARY EXPERTS 96
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 96
2.5 TOP-DOWN APPROACH 97
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 97
2.6 GROWTH FORECAST 98
FIGURE 8 CELL EXPANSION MARKET: CAGR PROJECTIONS 98
2.7 MARKET BREAKDOWN AND DATA TRIANGULATION 99
FIGURE 9 DATA TRIANGULATION METHODOLOGY 99
2.8 RESEARCH ASSUMPTIONS 100
2.9 MARKET FORECAST 100
TABLE 1 FACTOR ANALYSIS 100
2.10 RISK ANALYSIS 101
2.11 RECESSION IMPACT ANALYSIS 101
3 EXECUTIVE SUMMARY 102
FIGURE 10 CELL EXPANSION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 102
FIGURE 11 CELL EXPANSION MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION) 103
FIGURE 12 CELL EXPANSION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 103
FIGURE 13 CELL EXPANSION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 104
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF CELL EXPANSION MARKET 105
4 PREMIUM INSIGHTS 106
4.1 CELL EXPANSION MARKET OVERVIEW 106
FIGURE 15 GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET 106
4.2 ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT & COUNTRY (2023) 107
FIGURE 16 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC CELL EXPANSION MARKET IN 2023 107
4.3 CELL EXPANSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 108
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 108
4.4 CELL EXPANSION MARKET SHARE, BY END USER, 2023 108
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 108
5 MARKET OVERVIEW 109
5.1 INTRODUCTION 109
5.2 MARKET DYNAMICS 109
FIGURE 19 CELL EXPANSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 109
TABLE 2 CELL EXPANSION MARKET: IMPACT ANALYSIS 110
5.2.1 DRIVERS 110
5.2.1.1 Increasing incidence of chronic diseases 110
FIGURE 20 CANCER INCIDENCE, BY REGION, 2022 111
FIGURE 21 US: PERCENTAGE OF DEATHS CAUSED BY HEART DISEASE, 2021 111
5.2.1.2 Rising government investments in cell-based research and therapies 112
5.2.1.3 Growing focus on personalized medicine 112
FIGURE 22 PERCENTAGE OF PERSONALIZED MEDICINES IN FDA'S NEW DRUG APPROVALS, 2015–2022 113
5.2.1.4 Increasing GMP certifications for cell therapy production facilities 113
5.2.1.5 Growing strategic alliances for development of cell-based therapeutics 114
TABLE 3 STRATEGIC ALLIANCES IN CELL-BASED THERAPEUTICS 114
5.2.2 RESTRAINTS 114
5.2.2.1 Ethical concerns regarding research in cell biology 114
5.2.2.2 High cost of cell-based therapies 115
5.2.3 OPPORTUNITIES 115
5.2.3.1 High growth opportunities in emerging markets 115
5.2.3.2 Growing utility of 3D cell expansion technology 116
5.2.3.3 Growing automation in cell therapy manufacturing 116
5.2.4 CHALLENGES 117
5.2.4.1 Concerns regarding supply chain logistics 117
5.2.4.2 Challenges related to scale-up of cell and gene therapies 117
5.3 TECHNOLOGY ANALYSIS 118
5.3.1 KEY TECHNOLOGIES 118
5.3.1.1 Single-use technology 118
TABLE 4 ADVANTAGES OF SINGLE-USE BIOREACTORS AND CONVENTIONAL BIOREACTORS 118
5.3.1.2 Automated cell expansion 119
5.3.2 COMPLEMENTARY TECHNOLOGIES 119
5.3.2.1 High-throughput screening 119
5.3.2.2 Single-cell analysis 119
5.3.3 ADJACENT TECHNOLOGIES 120
5.3.3.1 Microfluidics and organ-on-a-chip 120
5.3.3.2 3D bioprinting 120
5.4 TRADE DATA 121
TABLE 5 IMPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND) 121
TABLE 6 EXPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND) 126
TABLE 7 IMPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS) 128
TABLE 8 EXPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS) 132
5.5 SUPPLY CHAIN ANALYSIS 134
FIGURE 23 CELL EXPANSION MARKET: SUPPLY CHAIN ANALYSIS 134
5.6 VALUE CHAIN ANALYSIS 135
FIGURE 24 CELL EXPANSION MARKET: VALUE CHAIN ANALYSIS 135
5.7 PRICING ANALYSIS 136
TABLE 9 AVERAGE SELLING PRICE OF CELL EXPANSION PRODUCTS 136
TABLE 10 AVERAGE SELLING PRICE OF CELL EXPANSION PRODUCTS, BY REGION 137
5.8 ECOSYSTEM ANALYSIS 138
FIGURE 25 CELL EXPANSION MARKET: ECOSYSTEM ANALYSIS 138
5.8.1 RAW MATERIAL VENDORS IN CELL EXPANSION MARKET 138
TABLE 11 CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS 138
5.8.2 PRODUCT VENDORS IN CELL EXPANSION MARKET 139
TABLE 12 CELL EXPANSION MARKET: ROLE OF PRODUCT VENDORS 139
5.8.3 END USERS IN CELL EXPANSION MARKET 139
TABLE 13 CELL EXPANSION MARKET: ROLE OF END USERS 139
5.8.4 REGULATORY BODIES GOVERNING CELL EXPANSION MARKET 140
TABLE 14 CELL EXPANSION MARKET: ROLE OF REGULATORY BODIES 140
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 140
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 140
5.10 PATENT ANALYSIS 141
5.10.1 METHODOLOGY 141
5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024 141
TABLE 15 PATENTS FILED, 2014–2024 141
5.10.3 INNOVATION AND PATENT APPLICATIONS 141
FIGURE 27 TOTAL NUMBER OF PATENTS GRANTED, 2014–2024 142
5.10.4 TOP APPLICANTS 142
FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024 142
TABLE 16 TOP 20 PATENT OWNERS IN CELL EXPANSION MARKET, 2014–2024 143
TABLE 17 PATENTS IN CELL EXPANSION MARKET, 2024 144
5.11 KEY CONFERENCES AND EVENTS 146
TABLE 18 CELL EXPANSION MARKET: KEY CONFERENCES AND EVENTS, 2024–2025 146
5.12 REGULATORY LANDSCAPE 148
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 148
TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 148
TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 148
TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 150
TABLE 22 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 150
5.12.2 REGULATORY SCENARIO 151
TABLE 23 CELL EXPANSION MARKET: REGULATORY GUIDELINES 151
5.13 PORTER’S FIVE FORCES ANALYSIS 153
TABLE 24 CELL EXPANSION MARKET: PORTER’S FIVE FORCES ANALYSIS 153
5.13.1 THREAT OF NEW ENTRANTS 154
5.13.2 THREAT OF SUBSTITUTES 154
5.13.3 BARGAINING POWER OF SUPPLIERS 154
5.13.4 BARGAINING POWER OF BUYERS 154
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 154
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 155
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 155
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL EXPANSION PRODUCTS 155
5.14.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS 155
5.14.3 BUYING CRITERIA FOR CELL EXPANSION MARKET 156
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 156
TABLE 25 BUYING CRITERIA FOR CELL EXPANSION PRODUCTS, BY END USER 156
5.15 INVESTMENT/FUNDING ACTIVITIES 157
6 CELL EXPANSION MARKET, BY PRODUCT 158
6.1 INTRODUCTION 159
TABLE 26 CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 159
6.2 CONSUMABLES 159
TABLE 27 CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 160
TABLE 28 CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 160
TABLE 29 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 30 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 31 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 32 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 33 MIDDLE EAST: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 34 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
6.2.1 MEDIA 163
TABLE 35 MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION) 163
TABLE 36 MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 164
TABLE 37 NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 38 EUROPE: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 39 ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 40 LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 41 MIDDLE EAST: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 42 GCC COUNTRIES: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 166
6.2.1.1 Serum-free media 166
6.2.1.1.1 Increasing utilization of serum-free components in cell research to promote market growth 166
TABLE 43 SERUM-FREE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 44 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 45 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 46 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 47 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 48 MIDDLE EAST: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 49 GCC COUNTRIES: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168
6.2.1.2 Classical media & salts 169
6.2.1.2.1 Used in cell expansion to provide supportive environment for growth and proliferation of cultured cells 169
TABLE 50 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022–2029 (USD MILLION) 169
TABLE 51 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 52 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 53 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 54 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 55 MIDDLE EAST: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 56 GCC COUNTRIES: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 171
6.2.1.3 Stem cell culture media 172
6.2.1.3.1 Rising investments and funding in stem cell research to support market growth 172
TABLE 57 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 172
TABLE 58 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 59 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 60 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 61 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 62 MIDDLE EAST: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 63 GCC COUNTRIES: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
6.2.1.4 Chemically defined media 175
6.2.1.4.1 Increasing number of cell-based research practices to drive market 175
TABLE 64 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 175
TABLE 65 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175
TABLE 66 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 67 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 68 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 69 MIDDLE EAST: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 70 GCC COUNTRIES: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177
6.2.1.5 Specialty media 178
6.2.1.5.1 Growing focus on advancement of regenerative medicine to drive growth 178
TABLE 71 EXAMPLES OF SPECIALTY MEDIA OFFERED BY KEY PLAYERS 178
TABLE 72 SPECIALTY MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION) 178
TABLE 73 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 74 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 75 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179
TABLE 76 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 77 MIDDLE EAST: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180
TABLE 78 GCC COUNTRIES: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180
6.2.1.6 Other media types 181
TABLE 79 OTHER MEDIA TYPES MARKET, BY REGION, 2022–2029 (USD MILLION) 181
TABLE 80 NORTH AMERICA: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 81 EUROPE: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 82 ASIA PACIFIC: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 83 LATIN AMERICA: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 84 MIDDLE EAST: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 85 GCC COUNTRIES: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
6.2.2 REAGENTS 183
6.2.2.1 Rising need for unique signaling molecules for cell proliferation to boost growth 183
TABLE 86 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 184
TABLE 87 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 88 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184
TABLE 89 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 90 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 91 MIDDLE EAST: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 92 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186
6.2.3 SERA 186
6.2.3.1 Growing R&D activities to drive demand for sera 186
TABLE 93 SERA MARKET, BY REGION, 2022–2029 (USD MILLION) 186
TABLE 94 NORTH AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 95 EUROPE: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 96 ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187
TABLE 97 LATIN AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 98 MIDDLE EAST: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 99 GCC COUNTRIES: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188
6.2.4 VESSELS 188
TABLE 100 VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 101 VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION) 189
TABLE 102 NORTH AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 103 EUROPE: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 104 ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 105 LATIN AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 106 MIDDLE EAST: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 107 GCC COUNTRIES: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191
6.2.4.1 Roller/roux bottles 192
6.2.4.1.1 Offer economic mean for large-scale cell expansion 192
TABLE 108 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022–2029 (USD MILLION) 192
TABLE 109 NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 110 EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 111 ASIA PACIFIC ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 112 LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 113 MIDDLE EAST: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 114 GCC COUNTRIES: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 194
6.2.4.2 Cell factory systems/cell stacks 195
6.2.4.2.1 Provide high-throughput and scalable solutions for large-scale cell expansion 195
TABLE 115 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022–2029 (USD MILLION) 195
TABLE 116 NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 195
TABLE 117 EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 196
TABLE 118 ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 196
TABLE 119 LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 120 MIDDLE EAST: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 121 GCC COUNTRIES: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 197
6.2.4.3 Flasks 198
6.2.4.3.1 Commonly used to offer large surface area for cell expansion 198
TABLE 122 FLASKS MARKET, BY REGION, 2022–2029 (USD MILLION) 198
TABLE 123 NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 124 EUROPE: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 125 ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 126 LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199
TABLE 127 MIDDLE EAST: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 128 GCC COUNTRIES: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 200
6.2.4.4 Multiwell plates 200
6.2.4.4.1 Single platform for multiple processes to obtain high-volume culture 200
TABLE 129 MULTIWELL PLATES MARKET, BY REGION, 2022–2029 (USD MILLION) 201
TABLE 130 NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 131 EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 132 ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 133 LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 134 MIDDLE EAST: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 135 GCC COUNTRIES: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 203
6.2.4.5 Cell expansion bags 203
6.2.4.5.1 Reduce risk of cross-contamination and ensure consistent culture conditions 203
TABLE 136 CELL EXPANSION BAGS MARKET, BY REGION, 2022–2029 (USD MILLION) 203
TABLE 137 NORTH AMERICA: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 138 EUROPE: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 139 ASIA PACIFIC: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 140 LATIN AMERICA: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 141 MIDDLE EAST: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 142 GCC COUNTRIES: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205
6.2.4.6 Petri dishes 206
6.2.4.6.1 Ease of use to support market growth 206
TABLE 143 PETRI DISHES MARKET, BY REGION, 2022–2029 (USD MILLION) 206
TABLE 144 NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206
TABLE 145 EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 146 ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 147 LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 148 MIDDLE EAST: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 149 GCC COUNTRIES: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208
6.2.5 OTHER CONSUMABLES 208
TABLE 150 OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 209
TABLE 151 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 152 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 153 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 154 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 155 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 156 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211
6.3 EQUIPMENT 211
TABLE 157 EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 158 EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 212
TABLE 159 NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 160 EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 161 ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 162 LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 163 MIDDLE EAST: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 213
TABLE 164 GCC COUNTRIES: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214
6.3.1 BIOREACTORS 214
TABLE 165 BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION) 214
TABLE 166 BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 167 BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 215
TABLE 168 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215
TABLE 169 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 170 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 171 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216
TABLE 172 MIDDLE EAST: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 217
TABLE 173 GCC COUNTRIES: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 217
6.3.1.1 Bioreactors, by Usage 217
6.3.1.1.1 Conventional Bioreactors 217
6.3.1.1.1.1 Widely used for large-scale manufacturing 217
TABLE 174 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 218
TABLE 175 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 176 EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218
TABLE 177 ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 178 LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 179 MIDDLE EAST: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 219
TABLE 180 GCC COUNTRIES: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 220
6.3.1.1.2 Single-use bioreactors 220
6.3.1.1.2.1 Increasing adoption of single-use equipment to boost segment growth 220
TABLE 181 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 221
TABLE 182 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 221
TABLE 183 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 221
TABLE 184 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 222
TABLE 185 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 222
TABLE 186 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 222
TABLE 187 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 223
6.3.1.2 Bioreactors, by Type 223
6.3.1.2.1 Microcarrier bioreactors 223
6.3.1.2.1.1 Offers high density of cells within small volume of media 223
TABLE 188 MICROCARRIER BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 224
TABLE 189 NORTH AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 224
TABLE 190 EUROPE: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 224
TABLE 191 ASIA PACIFIC: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 192 LATIN AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 193 MIDDLE EAST: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 225
TABLE 194 GCC COUNTRIES: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 226
6.3.1.2.2 Suspension-based independent bioreactors 226
6.3.1.2.2.1 Offer controlled environment for cell growth—key factor driving market growth 226
TABLE 195 SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 227
TABLE 196 NORTH AMERICA: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 227
TABLE 197 EUROPE: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 227
TABLE 198 ASIA PACIFIC: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 228
TABLE 199 LATIN AMERICA: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 228
TABLE 200 MIDDLE EAST: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 228
TABLE 201 GCC COUNTRIES: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 229
6.3.1.2.3 Hollow fiber bioreactors 229
6.3.1.2.3.1 Growing demand for perfusion-based cell expansion to drive growth 229
TABLE 202 HOLLOW FIBER BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 229
TABLE 203 NORTH AMERICA: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 204 EUROPE: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 205 ASIA PACIFIC: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 230
TABLE 206 LATIN AMERICA: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 231
TABLE 207 MIDDLE EAST: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 231
TABLE 208 GCC COUNTRIES: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 231
6.3.1.2.4 Other bioreactors 232
TABLE 209 OTHER BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 232
TABLE 210 NORTH AMERICA: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 232
TABLE 211 EUROPE: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 212 ASIA PACIFIC: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 213 LATIN AMERICA: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 233
TABLE 214 MIDDLE EAST: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 234
TABLE 215 GCC COUNTRIES: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 234
6.3.2 AUTOMATED CELL EXPANSION SYSTEMS 234
6.3.2.1 Increasing automation in cell & gene therapy manufacturing to boost demand 234
TABLE 216 AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 235
TABLE 217 NORTH AMERICA: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 235
TABLE 218 EUROPE: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 235
TABLE 219 ASIA PACIFIC: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 236
TABLE 220 LATIN AMERICA: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 236
TABLE 221 MIDDLE EAST: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 236
TABLE 222 GCC COUNTRIES: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 237
6.3.3 OTHER CELL EXPANSION EQUIPMENT 237
TABLE 223 OTHER CELL EXPANSION EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION) 237
TABLE 224 NORTH AMERICA: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 238
TABLE 225 EUROPE: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 238
TABLE 226 ASIA PACIFIC: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 238
TABLE 227 LATIN AMERICA: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 239
TABLE 228 MIDDLE EAST: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 239
TABLE 229 GCC COUNTRIES: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 239
7 CELL EXPANSION MARKET, BY CELL TYPE 240
7.1 INTRODUCTION 241
TABLE 230 CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION) 241
7.2 HUMAN CELLS 241
TABLE 231 CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 232 CELL EXPANSION MARKET FOR HUMAN CELLS, BY REGION, 2022–2029 (USD MILLION) 242
TABLE 233 NORTH AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 242
TABLE 234 EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 243
TABLE 235 ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 243
TABLE 236 LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 244
TABLE 237 MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 244
TABLE 238 GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 244
7.2.1 STEM CELLS 245
TABLE 239 CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 240 CELL EXPANSION MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION) 246
TABLE 241 NORTH AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 246
TABLE 242 EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 246
TABLE 243 ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 247
TABLE 244 LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 247
TABLE 245 MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 247
TABLE 246 GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 248
7.2.1.1 Adult stem cells 248
7.2.1.1.1 Rising funding for advancement of stem cell-based therapies to drive market 248
TABLE 247 CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY REGION, 2022–2029 (USD MILLION) 249
TABLE 248 NORTH AMERICA: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 249
TABLE 249 EUROPE: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 249
TABLE 250 ASIA PACIFIC: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 250
TABLE 251 LATIN AMERICA: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 250
TABLE 252 MIDDLE EAST: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 250
TABLE 253 GCC COUNTRIES: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 251
7.2.1.2 Embryonic stem cells 251
7.2.1.2.1 Rising prevalence of chronic diseases to support market growth 251
TABLE 254 CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY REGION, 2022–2029 (USD MILLION) 252
TABLE 255 NORTH AMERICA: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 252
TABLE 256 EUROPE: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 252
TABLE 257 ASIA PACIFIC: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 253
TABLE 258 LATIN AMERICA: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 253
TABLE 259 MIDDLE EAST: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 253
TABLE 260 GCC COUNTRIES: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 254
7.2.1.3 Induced pluripotent stem cells 254
7.2.1.3.1 Growing number of collaborations for advancement of iPSC-based therapies to drive market 254
TABLE 261 CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2022–2029 (USD MILLION) 255
TABLE 262 NORTH AMERICA: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 255
TABLE 263 EUROPE: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 255
TABLE 264 ASIA PACIFIC: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 256
TABLE 265 LATIN AMERICA: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 256
TABLE 266 MIDDLE EAST: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 256
TABLE 267 GCC COUNTRIES: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION) 257